Investor Presentaiton

о Highlights For personal use only Citadel Group | Investor Presentation | 6 Strong performance through COVID-19 reflects defensive nature of business model FY20 underlying revenue of $128.4m and underlying EBITDA of $29.2m in line with market consensus The acquisition of Wellbeing completed with financial performance in line with market consensus Successfully completed integration of Wellbeing into the Group, with synergies of $1.5m per annum commencing FY21 Secured channel partnerships and strategic relationships Opening up new local and international markets and actionable growth opportunities via partnerships with Micro Focus and LeanIX and establishing strategic relationship with Change Healthcare in the UK Successful integration of Noventus with early outperformance Noventus achieved $21.5m full year revenue, experiencing minimal impact from COVID-19 Strong balance sheet and capital management ahead of plan with net debt of $54.5m Cash position strong at $32.5m, gross bank debt of $86.5m Dividends for FY20 maintained at 10.8cps Final dividend declared of 6.0cps consistent with FY19

View entire presentation